au.\*:("NOORDZIJ M")
Results 1 to 12 of 12
Selection :
AIR CONDITIONING BASED ON THE OPTIMUM AIR SYSTEM = SYSTEME DE CONDITIONNEMENT D'AIR BASE SUR L'OPTIMISATION DE L'UTILISATION DE L'AIRNOORDZIJ M.1976; SHIPBUILDG MAR. ENGNG INTERNATION.; G.B.; DA. 1976; VOL. 99; NO 1198; PP. 234-239 (2P.)Article
Value of tissue markers p27kip1, MIB-I, and CD44s for the pre-operative prediction of tumour features in screen-detected prostate cancerVIS, A. N; VAN RHIJN, B. W. G; NOORDZIJ, M. A et al.Journal of pathology. 2002, Vol 197, Num 2, pp 148-154, issn 0022-3417Article
The prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomyNOORDZIJ, M. A; VAN STEENBRUGGE, G.-J; VERKAIK, N. S et al.Clinical cancer research. 1997, Vol 3, Num 5, pp 805-815, issn 1078-0432Article
The prognostic influence of neuroendocrine cells in prostate cancer : results of a long-term follow-up study with patients treated by radical prostatectomyNOORDZIJ, M. A; VAN DER KWAST, T. H; VAN STEENBRUGGE, G. J et al.International journal of cancer. 1995, Vol 62, Num 3, pp 252-258, issn 0020-7136Article
Determination of Ki-67 defined growth fraction by monoclonal antibody MIB-1 in formalin-fixed, paraffin-embedded prostatic cancer tissuesNOORDZIJ, M. A; VAN DER KWAST, T; VAN STEENBRUGGE, G. J et al.The Prostate. 1995, Vol 27, Num 3, pp 154-159, issn 0270-4137Article
Skin autofluorescence and risk of micro- and macrovascular complications in patients with Type 2 diabetes mellitus—a multi-centre studyNOORDZIJ, M. J; MULDER, D. J; OOMEN, P. H. N et al.Diabetic medicine. 2012, Vol 29, Num 12, pp 1556-1561, issn 0742-3071, 6 p.Article
Kinetics of neuroendocrine differentiation in an androgen-dependent human prostate xenograft modelJONGSMA, J; OOMEN, M. H; NOORDZIJ, M. A et al.The American journal of pathology. 1999, Vol 154, Num 2, pp 543-551, issn 0002-9440Article
Dexverapamil to modulate vinblastine resistance in metastatic renal cell carcinomaMICKISCH, G. H; NOORDZIJ, M. A; GAAST, A. V. D et al.Journal of cancer research and clinical oncology. 1995, Vol 121, pp R11-R16, issn 0171-5216, SUP3Conference Paper
The prognostic value of pretreatment expression of androgen receptor and bcl-2 in hormonally treated prostate cancer patients. CommentaryNOORDZIJ, M. A; BOGDANOWICZ, J. F. A. T; VAN KRIMPEN, C et al.The Journal of urology. 1997, Vol 158, Num 5, pp 1880-1885, issn 0022-5347Article
Androgen deprivation of the prohormone convertase-310 human prostate cancer model system induces neuroendocrine differentiationJONGSMA, J; OOMEN, M. H; NOORDZIJ, M. A et al.Cancer research (Baltimore). 2000, Vol 60, Num 3, pp 741-748, issn 0008-5472Article
Androgen-independent growth is induced by neuropeptides in human prostate cancer cell linesJONGSMA, J; OOMEN, M. H. A; NOORDZIJ, M. A et al.The Prostate. 2000, Vol 42, Num 1, pp 34-44, issn 0270-4137Article
Neuroendocrine differentiation in human prostatic tumor modelsNOORDZIJ, M. A; VAN WEERDEN, W. M; DE RIDDER, C. M. A et al.The American journal of pathology. 1996, Vol 149, Num 3, pp 859-871, issn 0002-9440Article
